AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: TAGRISSO (AstraZeneca) (tagrisso.com)
This site is a ‘regulatory fortress built on a template swamp.’ While the drug’s clinical substance is undeniable and well-cited, the digital delivery is plagued by unfinished placeholders and absurd H1 errors like the ‘pancakes’ slogan. It currently functions as a compliant but lazy brochure that fails to provide the authoritative patient-centered experience it promises.
Immediately remove the H1 ‘TAGRIS SOI can make pancakes’ and replace it with a semantic, keyword-rich heading regarding adjuvant treatment. Replace all ‘Inspirational quote to come’ placeholders with actual, dated patient testimonials that include specific diagnosis-to-treatment timelines. Implement Organization and Person schema to bridge the authority gap and link Dr. Gurubhagavatula to her professional credentials. Fix the broken heading hierarchy to ensure H2-H4 tags follow a logical information architecture rather than being used for legal boilerplate headers.
While the body text contains high-density clinical data and safety protocols required by the FDA, the heading structure is marred by template errors and placeholder content. The H1 TAGRIS SOI can make pancakes on sub-pages and the H1 TAGRIS SO I can… on the homepage are zero-substance slogans that fail to provide technical utility. Furthermore, multiple sections contain the explicit placeholder text Inspirational patient quote to come, indicating a significant gap where substantive evidence should be. The substance-to-fluff ratio is saved only by the legally mandated clinical descriptions of side effects and indications.
Hydration, modals, and JS dependent content erase entire sections of your page before AI can read them. Audit your AI visible surface to see what survives a script free crawl.
The homepage sets a signal of being a professional medical resource for cancer treatment, yet the sub-pages drift into unfinished template territory. The primary disconnect is found between the serious medical intent of the hero section and the amateurish execution of the H1 hierarchy on internal pages like ‘About Early-Stage NSCLC.’ There is also a drift in target audience engagement; the site invites professional trust but undermines it with visible development-phase copy like ‘Name X.’ These contradictions suggest a high-stakes medical claim supported by a low-effort content deployment.
Transition from a collection of strings to a machine verifiable identity. Generate your Clinical SEO Strategy to establish a robust Knowledge Graph Topology and eliminate semantic black holes.
The site displays a review_count of 1 on some pages without any actual review content or verifiable third-party source, creating a minor trust theatre flag. However, it avoids standard marketing BS by providing a proof_links_count of up to 15 on registration pages, mostly linking to privacy notices and regulatory disclosures. The most significant theatre is the use of ‘Patient Stories’ headers that currently lead to ‘quote to come’ placeholders, promising emotional proof that does not exist in the current crawl.
Proof density is split: the regulatory and clinical proof is high (1 in 5 patients statistics, specific mutation types), but the social proof is non-existent. For every specific clinical assertion, there is a corresponding ‘fluff’ placeholder such as ‘Name X’ or ‘Inspirational quote.’ Across 4 pages, we find 2 solid clinical study citations against 3 major template placeholders, resulting in a mediocre proof-to-assertion ratio for a biotech entity.
For a demonstration of entity driven retail architecture, open the Walmart Structured Data audit. View the Walmart Structured Data Audit to see how product, brand, and service entities are reconstructed for AI systems.
The site suffers from severe template fingerprints, evidenced by the repetitive use of industry-standard modules like ‘Caregiver Resources’ and ‘What to Ask Your Care Team’ that lack unique brand voice. The presence of developer-level placeholder text (Inspirational caregiver quote to come) is a definitive commodity red flag, suggesting the site was built using a generic pharmaceutical template that has not been fully customized. The value proposition of ‘precision medicine’ is unique to the molecule (osimertinib), but the delivery framework is a copy-paste of standard DTC pharma digital strategy.
Authority is primarily established through the AstraZeneca brand, but the site’s technical implementation lacks modern authority signals like schema_json, which is null across the board. While Dr. Sarada Gurubhagavatula is mentioned as an expert, there is no Person schema or sameAs links to verify her credentials or professional footprint. The technical credibility gap is widened by the broken heading hierarchy where H1 tags are used for non-semantic brand slogans rather than medical information.
The performance claims regarding TAGRISSO’s efficacy (e.g., ‘help prevent your lung cancer from coming back’) are generally backed by citations to clinical references like Sholl et al (2015). However, there is a disconnect in the ‘Patient Experience’ claims, which are framed as ‘Stories’ (Deb, Elise, Lloyd) but frequently lack the actual narrative substance or dated metrics in the body text. The site claims a supportive community but provides only a link to a general Facebook group, lacking integrated real-world evidence.
Medical Devices, Pharma & Biotech BS: TAGRISSO (AstraZeneca) (tagrisso.com)
The site content perfectly aligns with the Pharma & Biotech category, specifically focusing on oncology and targeted therapies for EGFR+ NSCLC. It utilizes heavy regulatory-required documentation such as Important Safety Information (ISI) and cites peer-reviewed studies (Sholl et al., D’Angelo et al.), confirming its status as a pharmaceutical product site.
AI cannot build a coherent graph if the same page resolves into multiple identities. Explore the URL & Canonical Hygiene Technical Framework to understand how identity stability prevents duplicate embeddings and semantic drift.
“The score of 45 is driven primarily by the 'Identity and Authority' and 'Information Density' pillars due to the catastrophic presence of placeholder text and nonsensical H1 headers. While the clinical data is highly substantive (lowering the potential score), the technical execution is so indicative of a generic template failure that it introduces significant 'Bullshit' via neglect. The lack of structured data and the presence of dummy names like 'Name X' are the primary credibility killers.”